Abbott Laboratories (ABT) Insider Trading & Ownership $131.86 -0.73 (-0.55%) As of 03:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Abbott Laboratories (NYSE:ABT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.46%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$33.04M Get ABT Insider Trade Alerts Want to know when executives and insiders are buying or selling Abbott Laboratories stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ABT Insider Buying and Selling by Quarter Abbott Laboratories Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/8/2025Philip P BoudreauCFOSell5,550$134.55$746,752.50 7/31/2025Michael T. McCaulU.S. Congress Member (R-TX)Buy$126.16$1,001 - $15,0007/21/2025Thomas H. Kean, Jr.U.S. Congress Member (R-NJ)Buy$124.27$1,001 - $15,0007/18/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$123.81$1,001 - $15,0007/10/2025Lisa C. McClainU.S. Congress Member (R-MI)Sell$133.64$1,001 - $15,0006/27/2025Michael T. McCaulU.S. Congress Member (R-TX)Sell$134.40$50,001 - $100,0006/24/2025Lisa C. McClainU.S. Congress Member (R-MI)Buy$138.13$1,001 - $15,0006/16/2025Michael T. McCaulU.S. Congress Member (R-TX)Sell$133.99$15,001 - $50,0005/12/2025Jefferson ShreveU.S. Congress Member (R-IN)Sell$131.90$50,001 - $100,0004/30/2025Sally E BlountDirectorSell2,600$129.66$337,116.00 4/23/2025Ro KhannaU.S. Congress Member (D-CA)Buy$129.83$1,001 - $15,0004/21/2025Bruce WestermanU.S. Congress Member (R-AR)Sell$130.00$1,001 - $15,0003/20/2025Byron DonaldsU.S. Congress Member (R-FL)Buy$126.72$1,001 - $15,0003/6/2025Lisa D EarnhardtEVPSell91,167$133.82$12,199,967.94 3/6/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$134.90$1,001 - $15,0003/3/2025Andrea F WainerEVPSell949$138.17$131,123.33 3/3/2025Eric ShroffSVPSell562$138.17$77,651.54 3/3/2025Bruce WestermanU.S. Congress Member (R-AR)Buy$140.13$1,001 - $15,0002/24/2025Shelley Moore CapitoU.S. Congress Member (R-WV)Sell$134.81$1,001 - $15,0002/13/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$131.83$1,001 - $15,0001/30/2025Daniel Gesua Sive SalvadoriEVPSell23,771$128.50$3,054,573.50 1/29/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$127.86$1,001 - $15,0001/28/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$127.28$1,001 - $15,0001/15/2025Jared MoskowitzU.S. Congress Member (D-FL)Sell$110.96$1,001 - $15,0001/8/2025Markwayne MullinU.S. Congress Member (R-OK)Sell$114.18$1,001 - $15,0001/6/2025Emily RandallU.S. Congress Member (D-WA)Sell$112.86$1,001 - $15,00012/16/2024Thomas H. Kean, Jr.U.S. Congress Member (R-NJ)Buy$112.64$1,001 - $15,00012/11/2024Markwayne MullinU.S. Congress Member (R-OK)Sell$114.15$15,001 - $50,0009/12/2024Robert B FordCEOSell141,679$116.41$16,492,852.39 9/4/2024John A Jr. MccoyVPSell27$114.83$3,100.41 (Data available from 1/1/2013 forward) ABT Insider Trading Activity - Frequently Asked Questions Who is on Abbott Laboratories' Insider Roster? The list of insiders at Abbott Laboratories includes Andrea F Wainer, Daniel Gesua Sive Salvadori, Daniel J Starks, Eric Shroff, John A Jr. Mccoy, John F Ginascol, Joseph J Manning, Jr. Robert E Funck, Julie L Tyler, Lisa D Earnhardt, Philip P Boudreau, Randel William Woodgrift, Robert B Ford, and Sally E Blount. Learn more on insiders at ABT. What percentage of Abbott Laboratories stock is owned by insiders? 0.46% of Abbott Laboratories stock is owned by insiders. Learn more on ABT's insider holdings. Which Abbott Laboratories insiders have been selling company stock? The following insiders have sold ABT shares in the last 24 months: Andrea F Wainer ($8,032,373.33), Daniel Gesua Sive Salvadori ($3,168,689.00), Daniel J Starks ($4,702,500.00), Eric Shroff ($77,651.54), John A Jr. Mccoy ($59,032.41), Jr. Robert E Funck ($1,055,843.29), Lisa D Earnhardt ($14,627,992.94), Philip P Boudreau ($746,752.50), Robert B Ford ($16,492,852.39), and Sally E Blount ($337,116.00). How much insider selling is happening at Abbott Laboratories? Insiders have sold a total of 420,689 Abbott Laboratories shares in the last 24 months for a total of $49,300,803.40 sold. Which members of congress are trading Abbott Laboratories? Michael T. McCaul (R-TX), Thomas H. Kean, Jr. (R-NJ), Lisa C. McClain (R-MI), Ro Khanna (D-CA), Byron Donalds (R-FL), Bruce Westerman (R-AR), and Josh Gottheimer (D-NJ) have bought shares of Abbott Laboratories in the last year totaling $80,000. Josh Gottheimer (D-NJ), Lisa C. McClain (R-MI), Michael T. McCaul (R-TX), Jefferson Shreve (R-IN), Bruce Westerman (R-AR), Shelley Moore Capito (R-WV), Jared Moskowitz (D-FL), Markwayne Mullin (R-OK), Emily Randall (D-WA), and John James (R-MI) have sold shares totaling $287,000. Abbott Laboratories Key ExecutivesMr. Robert B. Ford (Age 50)Chairman of the Board, President & CEO Compensation: $4.73MMr. Philip P. Boudreau (Age 51)CFO & Executive VP of Finance Compensation: $1.14M1 recent tradesMr. Hubert L. Allen (Age 58)Executive Vice President, General Counsel and Secretary Compensation: $2MMr. Daniel Gesua Sive Salvadori (Age 45)Executive VP and Group President of Established Pharmaceuticals & Nutritional Products Compensation: $1.76MMs. Lisa D. Earnhardt (Age 54)Executive VP & Group President of Medical Devices Compensation: $1.73M1 recent tradesMs. Sabina Ewing (Age 50)Senior VP of Business & Technology Services and Chief Information Officer Mr. Michael ComillaVice President of Investor Relations.Erica L. BattagliaVP and Chief Ethics & Compliance OfficerMs. Melissa BrotzVice President of Public Affairs & Corporate MarketingMr. Christopher J. Scoggins (Age 54)Senior Vice President of Commercial Operations, Marketing & Diabetes Care More Insider Trading Tools from MarketBeat Related Companies DexCom Insider Transactions Intuitive Surgical Insider Transactions Tesla Insider Transactions AbbVie Insider Transactions Boston Scientific Insider Transactions Elevance Health Insider Transactions Integer Insider Transactions Johnson & Johnson Insider Transactions Medtronic Insider Transactions Thermo Fisher Scientific Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (NYSE:ABT) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access